Parent eReferral to Tobacco Quitline

October 3, 2019 updated by: Children's Hospital of Philadelphia

Parent eReferral to Tobacco Quitline in Primary Care

Secondhand smoke (SHS) exposure is a significant public health problem in that it both harms children and is widely prevalent, affecting more than 40% of US children. Tobacco cessation quitlines are effective in helping smokers quit, but few smokers make use of their services. Electronic health record-based systems that automate referral of interested parents to quitlines through pediatric settings may increase the proportion of smokers who successfully enroll in treatment.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a randomized controlled study of electronic quitline referral compared to standard practice. Parent enrollment in the quitline will be reported to the study team by the state tobacco quitline, managed by the Pennsylvania Department of Health.

This is a single site study at one large outpatient pediatric practice. Eligible study participants are parents/caregivers (hereafter referred to as "parents"), 18 years of age or older, who are present for the child's healthcare (both well-child and acute) visit, who smoke, and who are interested in receiving treatment through the tobacco quitline.

The intervention is electronic referral to the tobacco quitline for parent smokers. The referral process will be embedded in a tobacco treatment clinical decision support (CDS) tool, created to help pediatricians provide counseling and treatment to parent smokers. The primary outcome of interest is smoker enrollment in the quitline, defined as the proportion of parent smokers identified in the clinic that enroll in quitline treatment compared across the intervention (electronic referral) and control (standard practice) approaches. Secondary outcomes include patient and parent demographic and behavioral factors associated with successful enrollment.

Study Type

Interventional

Enrollment (Actual)

484

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • Children's Hospital of Philadelphia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older
  • Parent/caregiver who presents for their child's healthcare (both well-child and acute) visit
  • Current smoker
  • Interested in being referred to the tobacco quitline

Exclusion Criteria:

  • Less than 18 years of age
  • Parent/caregiver who smokes but is not present during their child's healthcare visit
  • Not interested in referral to the tobacco quitline

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Electronic Quitline Referral
The electronic quitline referral will be embedded within the Tobacco Treatment CDS tool, a CDS system previously developed to help pediatricians provide smoking cessation counseling and treatment to parents who smoke, modeled off the CEASE intervention, an evidence-based approach for implementing smoking cessation treatment of parents in the pediatric setting. The parental tobacco treatment CDS tool prompts the pediatric clinician to ask the parent about smoking status and assess interest in quitting (at all well-child and acute visits), links to an electronic nicotine replacement therapy prescription for parents interested in quitting, and guides appropriate documentation. Electronic referral to the quitline will be made by clicking an automated link embedded in the tool that will send the parent smokers' names and telephone numbers (entered by the clinician) directly to the Pennsylvania (PA) Free Quitline.
The PA Free quitline is funded by the Pennsylvania Department of Health and staffed by trained cessation counselors available 24 hours a day, 7 days a week. Counseling is available in English and Spanish and can be provided in at least 15 additional languages through a third party. All smokers who enroll in smoking cessation treatment will receive counseling and support consistent with accepted clinical practice guidelines. This treatment includes as many as 5 proactive counseling calls, each designed to help develop problem-solving and coping skills, secure social support, and plan for long-term abstinence. Participants can also call an 800 telephone number as needed for additional support between calls. The timing of counseling calls will be relapse sensitive and include a call 1-2 days after the quit date, another telephone call a week after the first call, and additional calls generally occurring at 2-3-week intervals thereafter.
Other: Standard of Practice
All procedures implemented in the standard referral approach will be identical to those in the electronic referral approach with the exception of providing the telephone number for the Quitline to the parent (rather than electronic referral). The clinician workflow will be nearly the same, in that the clinician will use the link embedded in the tobacco treatment CDS tool to add the quitline to the patient's discharge paperwork (rather than automatically refer to the quitline).
The PA Free quitline is funded by the Pennsylvania Department of Health and staffed by trained cessation counselors available 24 hours a day, 7 days a week. Counseling is available in English and Spanish and can be provided in at least 15 additional languages through a third party. All smokers who enroll in smoking cessation treatment will receive counseling and support consistent with accepted clinical practice guidelines. This treatment includes as many as 5 proactive counseling calls, each designed to help develop problem-solving and coping skills, secure social support, and plan for long-term abstinence. Participants can also call an 800 telephone number as needed for additional support between calls. The timing of counseling calls will be relapse sensitive and include a call 1-2 days after the quit date, another telephone call a week after the first call, and additional calls generally occurring at 2-3-week intervals thereafter.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Parent Smokers Who Enrolled in Quitline
Time Frame: Through study completion, up to 1 year
Proportion of parent smokers identified in clinic that enroll in quitline treatment compared across the intervention (electronic referral) and control (standard of practice) approaches. Primary analysis wibased on an intent to treat approach and includes all subjects randomized at their referral visit.
Through study completion, up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Calls With the Quitline
Time Frame: Through study completion, up to 1 year
Total number of parent contacts with the quitline post-enrollment, compared between intervention and control and reported by the PA Quitline
Through study completion, up to 1 year
Number of Parents Who Quit Smoking
Time Frame: Through study completion, up to 1 year
Self-reported parent quit rates post-enrollment, compared between the intervention and control and reported by the PA Quitline
Through study completion, up to 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characteristics Associated With Successful Quitline Enrollment, Study Arm
Time Frame: Through study completion, up to 1 year
Multivariable logistic regression was used to assess demographic and behavioral factors which independently associated with successful enrollment. The Odds Ratios (ORs) from multivariable logistic regression model of characteristics associated with successful quitline enrollment.
Through study completion, up to 1 year
Characteristics Associated With Successful Quitline Enrollment, Patient Age
Time Frame: Through study completion, up to 1 year
Multivariable logistic regression was used to assess demographic and behavioral factors which independently associated with successful enrollment.
Through study completion, up to 1 year
Characteristics Associated With Successful Quitline Enrollment, Parent Age
Time Frame: Through study completion, up to 1 year
Multivariable logistic regression was used to assess demographic and behavioral factors which independently associated with successful enrollment.
Through study completion, up to 1 year
Characteristics Associated With Successful Quitline Enrollment, Asthma Diagnosis (Child)
Time Frame: Through study completion, up to 1 year
Multivariable logistic regression was used to assess demographic and behavioral factors which independently associated with successful enrollment.
Through study completion, up to 1 year
Characteristics Associated With Successful Quitline Enrollment, Cigarettes Smoked Per Day
Time Frame: Through study completion, up to 1 year
Multivariable logistic regression was used to assess demographic and behavioral factors which independently associated with successful enrollment.
Through study completion, up to 1 year
Characteristics Associated With Successful Quitline Enrollment, Quit Stage
Time Frame: Through study completion, up to 1 year
Multivariable logistic regression was used to assess demographic and behavioral factors which independently associated with successful enrollment.
Through study completion, up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexander Fiks, MD, MSCE, Children's Hospital of Philadelphia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 11, 2017

Primary Completion (Actual)

February 1, 2018

Study Completion (Actual)

August 1, 2018

Study Registration Dates

First Submitted

December 15, 2016

First Submitted That Met QC Criteria

December 16, 2016

First Posted (Estimate)

December 20, 2016

Study Record Updates

Last Update Posted (Actual)

October 28, 2019

Last Update Submitted That Met QC Criteria

October 3, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Secondhand Smoke

Clinical Trials on Quitline Delivered Treatment

3
Subscribe